0001562180-17-003959.txt : 20171219 0001562180-17-003959.hdr.sgml : 20171219 20171219210806 ACCESSION NUMBER: 0001562180-17-003959 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171216 FILED AS OF DATE: 20171219 DATE AS OF CHANGE: 20171219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oltmans Curtis Gale CENTRAL INDEX KEY: 0001714982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 171265583 MAIL ADDRESS: STREET 1: C/O ARRAY BIOPHARMA INC. STREET 2: 3200 WALNUT ST. CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-12-16 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001714982 Oltmans Curtis Gale C/O ARRAY BIOPHARMA, 3200 WALNUT ST. BOULDER CO 80301 false true false false General Counsel Restricted Stock Units 0.00 2017-12-16 4 A false 28000.00 0.00 A 2021-12-17 Common Stock 28000.00 28000.00 D Stock Option (Right to Buy) 10.92 2017-12-16 4 A false 168000.00 0.00 A 2027-12-16 Common Stock 168000.00 168000.00 D Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018. The option vests in four equal annual installments beginning on December 16, 2018. Curtis Oltmans 2017-12-19